Utah Medical Products Stock News

Utah Medical Products stock has dropped 14% and is at its lowest point this year due to ongoing lawsuits regarding its Filshie clip system. The lawsuits do pose a risk to UTMD's stock price, and a neg

Utah Medical Products comes with high returns on capital and projected earnings growth into FY'25. The company has compounded earnings at a rate of 2.8x that of revenue since 2021. Net-net, reiterate

Utah Medical Products: Recycling Capital Well, Long-Term Gains On The Table

UTMD is a relatively undercovered, unexploited name that historically trades within a narrow trading range, within a defensive sector. With this in mind, we wanted to see how it fits in within a cross

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Monthly update of the Dividend Champions List. 139 companies declared higher dividends in the past month, with an average increase of 10.54% over their previous payouts.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Utah Medical Products (UTMD) declares $0.29/share quarterly dividend, 1.8% increase from prior dividend of $0.285.Payable April 5; for shareholders of record March 18; ex-div March

Utah Medical Products, Inc. (NASDAQ:UTMD) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $108.86. Utah Medical Products shares last traded at $108.15, with a volume of 8,643 shares. The company has a market cap of $394.82 million, a []

Charles Schwab Investment Management Inc. lessened its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 13.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,558 shares of the medical instruments suppliers stock after selling 2,182 shares during the quarter. Charles Schwab Investment [] The post Charles Schwab Investment Management Inc. Reduces Position in Utah Medical Products, Inc. (NASDAQ:UTMD) appeared first on ETF Daily News .

State Street Corp trimmed its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 66,053 shares of the medical instruments suppliers stock after selling 3,088 shares during the period. State Street Corps holdings in Utah Medical Products were worth $5,636,000 at the end of the []

Northern Trust Corp reduced its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 6.1% during the second quarter, HoldingsChannel reports. The firm owned 40,535 shares of the medical instruments suppliers stock after selling 2,611 shares during the quarter. Northern Trust Corps holdings in Utah Medical Products were worth $3,447,000 as of its most []

Utah Medical Products, Inc. (NASDAQ:UTMD) Director Barbara A. Payne sold 751 shares of Utah Medical Products stock in a transaction on Wednesday, November 17th. The stock was sold at an average price of $111.06, for a total transaction of $83,406.06. The transaction was disclosed in a filing with the SEC, which can be accessed through []

SeaSpine (NASDAQ:SPNE) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings. Risk & Volatility SeaSpine has a beta of 1.12, meaning that its share price is []

SALT LAKE CITY, UT / ACCESSWIRE / August 3, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents